drugset / Trial / NCT00579189

Phase III Study of an Otic Formulation in Acute Otitis Media With Tympanostomy Tubes

NCT00579189

Phase 3 Completed 776 enrolled Alcon Research
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if a topical otic formulation is safe and effective in treating middle ear infections in patients with ear tubes.

Timeline

Start
2006-01
Primary completion
2009-01
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxidex Unknown Other
Comparator Moxifloxacin Small molecule Other

Indications